EDWARD T. WONG, M.D.; RICHARD P. DOE, M.D., Ph.D.
The long-acting thyroid stimulator (LATS) has been said to be the pathogenetic factor of the thyroid autonomy or hyperfunction in Graves' disease. Two patients had the ophthalmopathy and pretibial myxedema of Graves' disease occurring with Hashimoto's thyroiditis. Both patients had suppressed thyroid function in response to exogenous thyroid hormone in spite of the presence of high levels of LATS in their serums. The long-acting thyroid stimulator may not be the cause of the fixed thyroid function of Graves' disease.
Learn more about subscription options.
Register Now for a free account.
WONG ET, DOE RP. Suppressibility of Thyroid Function Despite High Levels of Long-Acting Thyroid Stimulator. Ann Intern Med. 1972;76:77–84. doi: 10.7326/0003-4819-76-1-77
Download citation file:
Published: Ann Intern Med. 1972;76(1):77-84.
Endocrine and Metabolism, Thyroid Disorders.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only